vazalore
Generic: aspirin
vazalore: developed by 1 company · 1 FDA decision.
vazalore evidence translation
What we can confirm
1 FDA record
What it means
Source-backed records connect vazalore to DPRX; that link alone does not prove the drug works.
What to watch
Watch for new trials or company disclosures after the FDA record.
BioSniper AIPage evidence connected
Prepared research question
How could vazalore → DPRX affect its developer, and what evidence supports the link?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
cardiovascular disease prevention and treatment, pain, inflammation and fever
Study sponsors
No additional listed-company sponsor is linked.
Development Pipeline (1)
| Company | Phase |
|---|---|
| PLX PHARMA INC. (DPRX) cardiovascular disease prevention and treatment, pain, infla… | Approved |
Frequently asked questions
Who is developing vazalore?
vazalore is being developed by PLX PHARMA INC..
What is vazalore's latest FDA decision?
The most recent tracked FDA decision for vazalore is Approval, dated January 14, 2013.